| Louise D Raspallo, CRNA | |
|
1725 Mendon Rd, Suite 203, Cumberland, RI 02864-4337 | |
| (401) 333-6100 | |
| (401) 333-6109 |
| Full Name | Louise D Raspallo |
|---|---|
| Gender | Female |
| Speciality | Anesthesiologist Assistant |
| Location | 1725 Mendon Rd, Cumberland, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386773521 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | CRNA021603 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Louise D Raspallo, CRNA 15 Louise Luther Dr, Cumberland, RI 02864-6013 Ph: (401) 334-1182 | Louise D Raspallo, CRNA 1725 Mendon Rd, Suite 203, Cumberland, RI 02864-4337 Ph: (401) 333-6100 |
News Archive
Participants in the weeklong residential "Perfect Health Program," developed by author and researcher Deepak Chopra, MD, had significant and lasting increases in perceived well-being and reductions in anxiety compared to a control group that experienced relaxation alone.
The United States Agency for International Development (USAID) and the Global Alliance for Improved Nutrition (GAIN) announced today $1 million to expand efforts to reduce the growing burden of malnutrition. The announcement will be made today at a historic gathering of the First Ladies of Africa, who convened to declare nutrition as a critical priority for eliminating poverty, improving health and advancing food security in their nations.
REGENERX BIOPHARMACEUTICALS, INC. (the "Company" or "RegeneRx") announced today that it received a "Notice of Allowance" in Europe for its patent application: Inhibition or Reversal of Skin Aging by Actin-Sequestering Peptides.
Diets rich in certain plant-based foods are linked with the presence of gut microbes that are associated with a lower risk of developing conditions such as obesity, type 2 diabetes and cardiovascular disease, according to recent results from a large-scale international study that included researchers from King's College London, the Harvard T.H. Chan School of Public Health, Massachusetts General Hospital, the University of Trento, Italy, and health science start-up company ZOE.
BIOLASE Technology, Inc. today announced that it has engaged Baltimore-based Levin Group, Inc., a leading international dental practice consulting firm, to develop a practice management system for the successful integration and implementation of BIOLASE dental lasers into everyday dental offices.
› Verified 4 days ago